₹0.02
(Market cap
₹1 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-1.2 %
-
ROCE
-0.6 %
-
Industry P/E
419.92
-
EV/EBITDA
-678
-
Debt to Equity
1.2
-
Book Value
₹--
-
EPS
₹-0.2
-
Face value
10
-
Shares outstanding
8,200,000
10 Years Aggregate
CFO
₹-11.68 Cr
EBITDA
₹-13.47 Cr
Net Profit
₹-16.22 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ABL Biotechnologies
| -- | -- | 1.7 | -47.1 | -38.1 | -37.9 | -33.1 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2014
|
|---|---|
|
ABL Biotechnologies
| -54.0 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ABL Biotechnologies
|
0.8 | 0.7 | -- | -0.1 | -- | -- | -- | 0.0 |
| 15.9 | 68.5 | 44.6 | -16.6 | -- | 0 | -- | -- | |
| 174.8 | 2,746.1 | 2,901.5 | 16.2 | 4.7 | 0.3 | 169.9 | 0.4 | |
| 28.9 | 8.8 | 0.2 | 0.0 | 14.4 | 0.5 | 419.9 | 2.2 | |
| 579.0 | 13,940.5 | 3,812.8 | 400.9 | 12.8 | 13.9 | 34.8 | 4.3 | |
| 74.8 | 269.2 | 137.7 | -9.4 | -8.1 | -9.2 | -- | 2.9 | |
| 329.7 | 14,931.8 | 3,171.8 | 521.3 | 19.3 | 18.1 | 28.9 | 4.7 | |
| 1,485.0 | 31,434.1 | 2,250.4 | 361.7 | 21.5 | 15.5 | 86.9 | 12.3 | |
| 16.1 | 240.8 | 84.6 | 12.8 | -2.1 | 20.8 | 18.8 | 7.5 | |
| 18.1 | 40.5 | 55.1 | -2.9 | 17.2 | -16.1 | -- | 0.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About ABL Biotechnologies
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1992
-
Chairman
K O Isaac
-
Managing Director
K O Isaac
-
Headquarters
Chennai, Tamil Nadu
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ABL Biotechnologies
What is the current share price of ABL Biotechnologies Ltd Today?
The share price of ABL Biotechnologies Ltd is ₹0.81 (BSE) as of 11-Jul-2016 IST. ABL Biotechnologies Ltd has given a return of -38.11% in the last 3 years.
What is the current PB & PE ratio of ABL Biotechnologies Ltd?
Since, TTM earnings of ABL Biotechnologies Ltd is negative, P/E ratio is not available.
The P/B ratio of ABL Biotechnologies Ltd is 0.05 times as on 11-Jul-2016, a 98 discount to its peers’ median range of 2.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2012 |
0.00 |
0.28 |
2011 |
0.00 |
0.50 |
2010 |
0.00 |
1.07 |
2009 |
0.00 |
0.28 |
2008 |
16.00 |
3.35 |
What is the 52 Week High and Low of ABL Biotechnologies Ltd?
The 52-week high and low of ABL Biotechnologies Ltd are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of ABL Biotechnologies Ltd?
ABL Biotechnologies Ltd has a market capitalisation of ₹ 1 Cr as on 11-Jul-2016. As per SEBI classification, it is a company.
Should I invest in ABL Biotechnologies Ltd?
Before investing in ABL Biotechnologies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.